Details of the Drug

General Information of Drug (ID: DMJ7U4G)

Drug Name

PEK fusion protein vaccine

Indication

Disease Entry	ICD 11	Status	REF
Cervical cancer	2C77.0	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01880411) Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine. U.S. National Institutes of Health.